Company page
Hangzhou Tigermed Consulting Co., Ltd. Class A
Hangzhou Tigermed Consulting Co., Ltd. Class A is a public company based in China, trading under the ticker 300347. The company has a market capitalization of approximately 4.5 billion USD. Tigermed specializes in providing comprehensive clinical trial services and solutions to the pharmaceutical and biotechnology industries.
- Ticker
- 300347:SZSE
- Asset type
- Stock
- Market cap
- $4.50B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- SZSE
- Currency
- CNY